Alzheimer treatment videos (click here
to see videos of actual treatment results)
The patented** Tobinick anti-TNF
method for treatment of Alzheimer's disease
as seen on the BBC,
New
Scientist, CNN, Fox News, ABC News, Bloomberg News, Reuters
Health, the Times Online (U.K.), the Daily Telegraph(U.K.),
UPI, and discussed on Medscape,
in a university
press release, and in Nature
Clinical Practice Neurology
*New: Physician Training Program:click
here
The Tobinick
Alzheimer Method™ is a unique, pioneering, patented**
off-label treatment method for selected patients with Alzheimer's
Disease who have failed to adequately respond to conventional
medical treatment. The concept of TNF-inhibition for treatment
of neurodegenerative disease has recently been reviewed (Tweedie D, Sambamurti K, Greig NH. Drug
Design & Development Section, Laboratory of Neurosciences,
Intramural Research Program, National Institute on Aging, National
Institutes of Health, Baltimore, MD 21224, US. TNF-alpha Inhibition
as a Treatment Strategy for Neurodegenerative Disorders: New Drug
Candidates and Targets. Curr Alzheimer Res. 2007 Sep;4(4):375-8). The publications and patents of Edward
Tobinick MD have been cited by an
increasing number of scientific and patent publications from academic and pharmaceutical researchers
from around the world.
This unique treatment program
is currently open to a limited number of new patients. Appointments for consultation for evaluation
can be scheduled by calling the INR at (310) 824-6199,
Monday through Friday 9 AM to 5 PM.
*For a more detailed scientific
explanation, please see the For physicians
and scientists webpage. Videos of family members discussing
their observations of the effect of treatment of Alzheimer's utilizing
the Tobinick Method™ at the INR can be viewed on the Alzheimer treatment videos webpage.
To download a PDF copy of our newly published article reporting
the results of treatment utilizing the Tobinick Alzheimer Method™,
entitled "Rapid cognitive improvement
in Alzheimer's disease..., please click here.
The importance of the article was demonstrated by its selection
and evaluation on F1000 Biology
with an "exceptional" rating, classified as a potential
landmark paper representing the top 1% of publications. It was
accompanied by an editorial about the Tobinick Method™, also
available as a PDF download. The
article has now also been selected for discussion
in a leading neurology journal, Nature
Clinical Practice Neurology.
Institute for Neurological
Research, a private
medical group, inc.
100 UCLA Medical Plaza, Suites 205-210 Los Angeles, California
90095
Edward Tobinick MD,
Director
Appointments
and Information: (310) 824-6199
<Map
and Directions><Appointments><Terms of Use><Memory
Disorders Program-detailed brochure (PDF)><Alzheimer
treatment videos><Dementia><Citations to INR publications>
Copyright ©2008,
the Institute for Neurological Research® (INR®), a private
medical group, inc., all rights reserved. **U.S. patents 6015557,
6177077, 6419934, 6419944, 6471961, 6537549, 6982089, 7214658
and additional issued and pending U.S. and foreign patents. These
patents are assigned to TACT IP LLC. Tobinick Alzheimer Method™ and Tobinick Method™
are trademarks of the INR.